BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 1387849)

  • 1. The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study.
    Younis JS; Simon A; Koren R; Dorembus D; Schenker JG; Laufer N
    Fertil Steril; 1992 Sep; 58(3):575-80. PubMed ID: 1387849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant growth hormone for induction of ovulation with gonadotrophin-releasing hormone agonist and gonadotrophins in polycystic ovary syndrome: a randomized, double-blind, placebo controlled trial.
    Homburg R; Levy T; Ben-Rafael Z
    Hum Reprod; 1995 Oct; 10(10):2550-3. PubMed ID: 8567768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect of growth hormone and gonadotropins in achieving conception in "clonidine-negative" patients with unexplained infertility.
    Blumenfeld Z; Amit T; Barkey RJ; Lunenfeld B; Brandes JM
    Ann N Y Acad Sci; 1991; 626():250-65. PubMed ID: 1905509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double-blind study.
    Dor J; Seidman DS; Amudai E; Bider D; Levran D; Mashiach S
    Hum Reprod; 1995 Jan; 10(1):40-3. PubMed ID: 7745068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
    Westergaard LG; Erb K; Laursen S; Rasmussen PE; Rex S
    Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luteinizing response to human chorionic gonadotropin does not predict outcome in gonadotropin releasing hormone agonist-suppressed/human menopausal gonadotropin-stimulated in vitro fertilization (IVF) cycles.
    Penzias AS; Shamma FN; Gutmann JN; Seifer DB; DeCherney AH; Lavy G
    J Assist Reprod Genet; 1992 Jun; 9(3):244-7. PubMed ID: 1525454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
    Jiang S; Kuang Y
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrashort gonadotropin-releasing hormone agonist (GnRH-a) protocol in comparison with the long-acting GnRH-a protocol and menotropin alone.
    Ron-El R; Herman A; Golan A; Soffer Y; Nachum H; Caspi E
    Fertil Steril; 1992 Dec; 58(6):1164-8. PubMed ID: 1459267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison between a standard and reduced dose of D-Trp-6-luteinizing hormone-releasing hormone administered after pituitary suppression for in-vitro fertilization.
    Simon A; Benshushan A; Shushan A; Zajicek G; Dorembus D; Lewin A; Laufer N
    Hum Reprod; 1994 Oct; 9(10):1813-7. PubMed ID: 7844208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does prolonged pituitary down-regulation with gonadotropin-releasing hormone agonist improve the live-birth rate in in vitro fertilization treatment?
    Ren J; Sha A; Han D; Li P; Geng J; Ma C
    Fertil Steril; 2014 Jul; 102(1):75-81. PubMed ID: 24746740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interest of growth hormone-releasing hormone administration for improvement of ovarian responsiveness to gonadotropins in poor responder women.
    Hugues JN; Torresani T; Herve F; Martin-Pont B; Tamboise A; Santarelli J
    Fertil Steril; 1991 May; 55(5):945-51. PubMed ID: 1827076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of growth hormone on granulosa cell function during in-vitro fertilization.
    Younis JS; Ezra Y; Brzezinnski A; Fibich T; Schenker JG; Laufer N
    Hum Reprod; 1993 Oct; 8(10):1588-92. PubMed ID: 8300811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of growth hormone on follicular fluid androgen levels in patients treated with gonadotropins before in vitro fertilization.
    Bergh C; Carlström K; Selleskog U; Hillensjö T
    Eur J Endocrinol; 1996 Feb; 134(2):190-6. PubMed ID: 8630518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of GnRH analogue therapy in IVF in women with unexplained infertility.
    Ashkenazi J; Dicker D; Feldberg D; Goldman GA; Yeshaya A; Goldman JA
    Hum Reprod; 1989 Aug; 4(6):667-9. PubMed ID: 2528570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology.
    Suikkari A; MacLachlan V; Koistinen R; Seppälä M; Healy D
    Fertil Steril; 1996 Apr; 65(4):800-5. PubMed ID: 8654642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective randomized study of human menotropin versus a follicular and a luteal phase gonadotropin-releasing hormone analog-human menotropin stimulation protocols for in vitro fertilization.
    Maroulis GB; Emery M; Verkauf BS; Saphier A; Bernhisel M; Yeko TR
    Fertil Steril; 1991 Jun; 55(6):1157-64. PubMed ID: 1903732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of growth hormone administration on human ovarian function and steroidogenic gene expression in granulosa-luteal cells.
    Tapanainen J; Martikainen H; Voutilainen R; Orava M; Ruokonen A; Rönnberg L
    Fertil Steril; 1992 Oct; 58(4):726-32. PubMed ID: 1426317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased progesterone/estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization-embryo transfer cycles with a long gonadotropin-releasing hormone agonist.
    Younis JS; Matilsky M; Radin O; Ben-Ami M
    Fertil Steril; 2001 Aug; 76(2):294-9. PubMed ID: 11476775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of short 7-day and prolonged treatment with gonadotropin-releasing hormone agonist desensitization for controlled ovarian hyperstimulation.
    Hazout A; de Ziegler D; Cornel C; Fernandez H; Lelaidier C; Frydman R
    Fertil Steril; 1993 Mar; 59(3):596-600. PubMed ID: 8458463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between follicular fluid content and the results of in vitro fertilization and embryo transfer. III. Proteoglycans.
    Franchimont P; Hazee-Hagelstein MT; Hazout A; Gysen P; Salat-Baroux J; Schatz B; Demerle F
    Biol Reprod; 1990 Aug; 43(2):183-90. PubMed ID: 2143088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.